The brains of Alzheimer's Disease patients show a decrease in brain mass and a 27 preponderance of extracellular Amyloid-β plaques. These plaques are formed by aggregation 28 of polypeptides that are derived from Amyloid Precursor Protein (APP). Amyloid-β plaques 29 are thought to play either a direct or an indirect role in disease progression, however the exact 30 role of aggregation and plaque formation in the ethology of Alzheimer's Disease is subject to 31 debate, not least because the biological effects of soluble and aggregated Amyloid-β peptides 32 are difficult to separate in vivo. To investigate the consequences of formation of Amyloid-β 33 oligomers in living tissues, we developed a fluorescently tagged, optogenetic Amyloid-β 34 peptide that oligomerizes rapidly in the presence of blue light. We applied this system to the 35 crucial question of how intracellular Amyloid-β oligomers underlie the pathologies of 36
Introduction 45
Alzheimer's disease (AD) is a debilitating, age-associated, neurodegenerative disease which 46 affects more than 46.8 million people worldwide and represents the 6th leading cause of 47 death in the United States of America (Ahn et clinical trial landscape has largely been dominated by the amyloid cascade hypothesis, with 52 more than 50% of the drugs targeting amyloid beta (A) in Phase III trial alone (Cummings 53 et al. 2018 ). The amyloid cascade hypothesis, in its original form, posits the deposition of 54 A, in particular the extracellular A plaque, as the main driver of AD (Hardy et al. 1992) . 55
However, the causative role of A plaque has been challenged recently, not least because of 56 the failure of numerous interventions targeting A plaque in Phase III trials (Cummings 57 2018) and the observation of Aβ plaques in brains of non-AD symptomatic individuals. 58
Model organisms ranging from nematodes to mice have further shown that AD pathology can 59 be modeled in the absence of obvious Aβ plaques (Duff et al. 1996 , Fong et al. 2016 ). These 60 observations point to a different mechanism for Aβ neurotoxicity perhaps through Aβ's 61 intracellular accumulation (LaFerla et al. 2007) . 62 63 Amyloid plaques are macroscopic extracellular protein aggregates, but intracellular Aβ must 64 function in smaller units of single peptides, oligomers or aggregates. Of these, soluble Aβ 65 oligomers appear to be the main toxic species in AD (Ferreira et al. 2011) . For example, Aβ 66 oligomers have been shown to induce neurotoxic effects including memory loss in transgenic 67 animal models (reviewed in (Mroczko et al. 2018) ). These studies, however, mostly rely on 68 in vitro injection of synthetic Aβ oligomers or oligomers extracted from AD brains 69 (Mroczko, Groblewska et al. 2018 ). There is currently a lack of tools that can directly control 70
Aβ oligomerization in vivo, which will allow direct examination of the effects of Aβ 71 oligomerization. 72
73
Here we describe an optogenetic method to study Amyloid-β (Aβ) protein oligomerization in 74 vivo in different model organisms and apply it to delineating mechanisms of disease 75 progression. Optogenetics hinges on light responsive proteins that can be fused to genes of 76 interest, allowing for the spatial and temporal regulation of proteins in a highly precise 77 manner. Temporal-spatial control is achieved simply by the exposure of the target system to 78 lights of a specific wavelength, without the need to introduce other external agents (Fenno et 79 al. 2011 ). One such optogenetic protein, a modified version of the Arabidopsis 80 cryptochrome2 (CRY2) protein, oligomerizes quickly and reversibly in the presence of blue 81 light at 488nm. CRY2 fusion proteins have, for instance, been used to study cortical actin 82 dynamics in cell contractility during tissue morphogenesis, the dynamics of Wnt and EGF 
97
We generated transgenic animals expressing the 42-amino-acid human Aβ peptide (Aβ1-42) 98 fused to Cryptochrome2 and the fluorescent protein mCherry (Aβ-CRY2-mCh). Drosophila 99 lines were under the control of the GAL4/UAS system (Brand et al. 1993 ) and expressed 100 either ubiquitously via AD-Gal4 driver (Figure 1b-c) or specifically in neurons using Elav-101
Gal4 driver (Figure 1d -e, S1). C. elegans lines were made with the heat shock promoter 102 ( Figure 1f -h, S2). In order to observe oligomerization and clustering of intracellular Aβ, we 103 took a live imaging approach in Drosophila embryos using a lightsheet microscope with a 104 488nm laser activating CRY2 and the 561nm laser imaging mCh over time. We observed 105 clusters of mCh fluorescence forming in embryos exposed to 488nm light, but fewer in 106 embryos that were not exposed to blue light ( Figure S3 , Movies 1-2). The intensity of the 107 clusters was quantified using Imaris quantification software to show the intensity of oligomer 108 formation ( Figure 1c ). 109
110
We proceeded to test the effectiveness of light induced clustering of Aβ-CRY2-mCh in C. 111 elegans. As this construct is driven by a heat shock promoter, worms were heat shocked at 112 35°C for 90 minutes followed by resting at 20°C before being immobilized and imaged using 113 confocal microscopy (Figure 1f-h). We observed an increase in clusters in worms exposed to 114 blue light over their siblings not exposed to blue light. The results were quantified as 115 fluorescence intensity and represented in (Figure 1h ) showing the formation of Aβ clusters. 116
Even though the CRY2 system predominantly oligomerizes, we also observed the formation 117 of intracellular Aβ aggregates, using a direct stain for Aβ aggregates ( Figure S4 ). 118
Importantly, we observed that Aβ aggregation was not reversible as had previously been 119 observed for signaling molecules (Huang, Amourda et al. 2017 , Johnson, Goyal et al. 2017 , 120 Kaur, Saunders et al. 2017 , rather CRY2 appears to initiate clustering leading to Aβ bundles 121 that do not come apart once blue light is turned off. We further confirmed that turning on 122 blue light alone without the transgene expression did not lead to any Aβ expression or cluster 123 formation ( Figure S2b , Ab HS L vs Ab -HS L), suggesting that the oligomerization process 124 is CRY2-specific and not an artifact of light. Together, our results showed that the Aβ-125 CRY2-mCh transgene is functional in both organisms, with a high specificity to blue light, 126 which induces irreversible oligomerization of Aβ. 127 128
Light-inducible Aβ oligomerization causes lifespan and behavioral deficits in transgenic 129 models 130
To test the functionality of Aβ-CRY2-mCh, we next looked for phenotypes associated with 131 light-induced intracellular Aβ oligomerization. We performed lifespan studies to assess the 132 effects of Aβ-CRY2-mCh by expressing Aβ-CRY2-mCh either ubiquitously (AD-Gal4) or 133 specifically in the nervous system (Elav-Gal4). Newly eclosed adult flies were separated into 134 two groups in each case, one of which was exposed to ambient white light and the other kept 135 in the dark. In both cases, flies exposed to light died much more quickly with half the mean 136 and maximum lifespans (Figure 2a -b) compared to those reared in the dark. We extended 137 this analysis to C. elegans, though starting at Day 6 due to the heat-shock manipulation step. 138
Under light conditions, C. elegans showed markedly decreased lifespans as compared to the 139 transgenic C. elegans kept in dark conditions ( Figure 2c ). Most significantly, we observed 140 that the lifespan decrease was reversible, as taking animals exposed to light for 24 days and 141 moving them into darkness showed a recovery of their lifespan, or a rescue (Figure 2a -b). To 142 ensure that these reduced lifespans were physiological, we examined the fitness of the 143 animals. Fitness was severely decreased in light-exposed flies and worms as quantified by 144 fertility and locomotive assays ( Figure The severity of the physical damage phenotype in embryos exposed to blue light ( Figure 3a -164 d'') led us to investigate the differences in mechanism between the two conditions by 165 exploring inflammatory response, mitochondrial health and oxidative damage. Expression of 166
Aβ alone, without light-induced Aβ oligomerization, led to a small increase in inflammatory 167 markers ( Figure 3e ) (Westfall et al. 2018 ). In embryos exposed to light, two of these markers 168 increased to a much greater level ( Figure 3e ). We observed a significant reduction the 169 number of mitochondria light-treated Aβ animals ( Figure 3f ). Markers of oxidative damage 170 in light and dark exposed C. elegans showed differential expression of antioxidant defense 171 genes, specifically Catalase, Trx-2 and Sod-3, suggestive of the occurrence of oxidative stress 172 induced by Aβ oligomerization (Figure 4 ). These results suggested that light-induced Aβ 173 oligomerization phenocopies many of the hallmarks of AD. 174
175
We proceeded to look at light-induced Aβ oligomerization in metabolic impairments in 176 transgenic C. elegans. Heat-shocked mutants exposed to light (Aβ HS L) had lower ATP 177 levels compared to the non-transgenic control (Ctrl -HS D) ( Figure 5 ). However, heat-178 shocked mutants in dark condition (Aβ HS D) did not show any significant differences in 179 ATP level compared to the non-transgenic control. This result suggested that presence of Aβ 180 alone is insufficient to induce ATP deficits, and that light-induced oligomerization of Aβ is 181 required for the defect to manifest. Aβ expression alone was also insufficient to affect the 182 nematodes' maximum respiratory capacity, as heat-shocked mutants in dark condition (Aβ 183 HS D) did not display differences in maximum and spare respiration capacity compared to 184 Taken together, these studies point to a putative AD therapeutic intervention that is based on 202 the activation of the Wnt signaling cascade through Li + . To test the usefulness of optogenetic 203
Aβ for drug testing, we supplemented the food for Drosophila expressing Aβ-CRY2-mCh 204 with Li + . Drosophila exposed to light, but consuming Li + had significantly increased 205 lifespans, suggesting a rescue effect induced by Li + (Figure 2a-b) , and that the optogenetic 206 model can be used for inducible expression drug testing. Rapid drug testing can be also be 207 achieved through cell culture. We extended this assay to HEK293 cells transfected with Aβ-208 CRY2-mCh. These showed Aβ clusters forming upon stimulation with blue light, but the 209 clustering was ameliorated by the addition of Li + or the specific GSK3 inhibitor CHIR99021 210 ( Figure S7 ). These data demonstrate the potential use of our optogenetics system for drug 211 testing. 212 213 Finally, we also extended these findings to a vertebrate system. We generated a zebrafish 214 permanent line with UAS: Aβ-CRY2-mCh in the transgenic TgBAC(gng8:GAL4) c416 215 background (Hong et al. 2013 ). We observed a diffuse mCh fluorescence in a small subset 216 of neurons in the olfactory epithelium, the interpeduncular nucleus and in a few neurons 217 sparsely distributed in the forebrain at 5 dpf. Upon blue light exposure (488 nM) the 218 detectable intensity of the fluorescence increased rapidly ( Figure S8 ). Several neurons 219 among those expressing appeared to bleb and began to die within 40 to 50 minutes of initial 220 exposure to the blue light (Movie 4). 221
Discussion 222
To the best of our knowledge, this is the first study to demonstrate that induced 223 oligomerization of intracellular Aβ mediates AD pathologies and that different pathologies 224 oligomerization also leads to physical damage of the nervous system, resembling the loss of 236 brain tissue in AD ( Figure S8 ). The embryonic assay for physical damage phenocopies brain 237 lesions only to some extent as the extent of the damage is enhanced by the forces applied to 238 the developing neural tissue. The irreversibility of Aβ aggregates once initiated as seen here, 239 also hints at intrinsic properties that may be unique or unusual to this peptide and warrants 240 further investigation. It is also likely to prove a good model for testing anti-aggregation 241
compounds. 242 243
We anticipate that our approach will serve as an attractive tool for carrying out drug screens 244 and mechanistic studies for the treatment of AD. This optogenetic strategy will also 245 undoubtedly complement other techniques due to the high level of spatiotemporal specificity. 246
For example, it could be optimally positioned to gain insights into the unresolved mechanism 247 of Aβ -whether oligomerization and subsequent accumulation or lack of effective clearance 248 underpins AD pathologies. The separation of two phases of AD progression also suggests 249 that single drug treatments will not suffice, and perhaps combinatorial approaches should be 250 Non-heat shock controls were used for lifespan, fertility and locomotion studies. 309 310
Lifespan Assays 311
Drosophila and C. elegans were counted daily for the number of dead subjects and the 312 number of censored subjects (excluded from the study). Drosophila that failed to respond to 313 taps were scored as dead and those stuck to the food were censored. C. elegans that failed to 314 respond to plate-tapping were scored as dead, those that burrowed to the side of the plate 315 were censored. 316 317
Locomotion assay 318
Drosophila locomotion was assessed using an established geotaxis assay previous described 319 in (Rival et al. 2009 ). In brief, 25 Drosophila were enclosed in a plastic column (25cm tall, 320 
Food race assay 340
Food race assay adapted from Nyamsuren et al. (Nyamsuren et al. 2007 ) was conducted using 341 94mm NGM plates seeded with 0.2mL of OP50-1 at a designated food spot. A starting spot 342 60mm away from the food spot was marked on the plate. 30 D2 adult worms from each 343 condition 24hrs post heat-shock were placed on the starting spot and left to roam at room 344 temperature. After 15min, the number of worms that reached the food spot and the number of 345 worms that left the starting spot were tabulated. Mobility index was calculated by dividing 346 the number of worms that reached the food spot by the number of worms that left the starting 347 spot. 3 technical repeats were conducted for each condition. 
Light-sheet microscopy 365
Drosophila embryos were dechorionated using bleach, rinsed twice with water and dried, and 366 loaded into a capillary filled with 1% low-melting agarose Type VII-A in water (Sigma) 367 (Colosimo et al. 2006 ). C.elegans and D. rerio were embedded directly in the agarose. 368
Samples were imaged with a Lightsheet Z.1 microscope. Cry2 was activated by a dual-side 369 illumination with 10% power 488nm laser for 29.95ms for every 2.5minutes for 500 cycles. 370
Controls were only exposed to 561nm. Images were acquired with a water immersion 
Immunofluorescence & Confocal microscopy 386
Drosophila embryos 9 hours after deposition were incubated at 25°C in either light or dark 387 conditions for 13 hours before being dechorionated using bleach. Embryos were then fixed 388 with Heat-Methanol treatment (Müller et al. 1996) or with heptane/4% formaldehyde in 389 phosphate buffer (0.1M NaPO4 pH 7.4) . Staining, detection and image 390 processing as described in (Colosimo and Tolwinski 2006) . For detection of Aβ aggregates, thioflavin T (ThT) staining were performed as previously 399 described (Iijima et al. 2008 ). Formaldehyde-fixed embryos were incubated in 50% EtOH 400 containing 0.1% ThT (Sigma) overnight. Embryos were destained in 50% EtOH for 10 401 minutes, followed by three washes in PBS. Embryos were then mounted on microscope 402 slides using Aquapolymount (Polysciences, Inc.). 403
404
Images were acquired on the Zeiss LSM 800 (Carl Zeiss, Germany) using the following 405 settings: 1% laser power for 488nm; 5% laser power for 561nm; 2% laser power for 647nm. 406
Images were processed using the ZEN 2014 SP1 software (Carl Zeiss, Germany) and Imaris 407 (Bitplane AG). 408
409

RNA Extraction, cDNA Synthesis and qPCR 410
Drosophila embryos 9 hours after deposition were incubated at 25°C in either light or dark 411 conditions for 13 hours were used. Embryos were dechorionated and washed with 100% 412 ethanol prior to RNA extraction using the ISOLATE II RNA Mini Kit's protocol (Bioline, 413 UK). The extracted RNA was quantified using Nanodrop (Thermo Fisher Scientific). cDNA 414 synthesis was done according to the SensiFAST™ cDNA Synthesis Kit's protocol (Bioline). 415
Primers pairs used: AttA, IMD, DptA, Def, Duox, Rel, catalase, Prdx3, Trx1, Trx2, SOD-1, 416 SOD-2, SOD-3 and reference gene Rpl32. Quantitative PCR was performed using SYBR® 417
Green. Expression data were normalized to the dark controls. For mitochondrial copy 418 number, the above collection method was used except the following: the embryos were stored 419 in tritonX-100 and the primers used were Mitochondria Cytochrome b (MtCyb) and reference 420 gene RNAse P. 421 422
Image Data & Statistical Analysis 424
Aβ aggregates were quantified in Drosophila using ImageJ (NIH) and in C. elegans with 425 IMARIS. For statistical analysis of the expression of genes, student's t-test was used for 426 except for cases where the data showed unequal standard deviation (F-test, p<0.05), in which 427 the Mann-Whitney nonparametric test was performed. Statistical analysis of lifespan studies 428 and behavioral assays were performed using OASIS2 6. The number of samples was 429 determined empirically. All graphs were plotted using Graphpad PRISM 6 (Graphpad driven by AD-Gal4 kept in the dark, exposed to light, exposed to light for 24 days then 453 moved to the dark and exposed to light but fed with a lithium-supplemented diet. (b) Meier survival curves of transgenic Aβ Drosophila adults driven by Elav-Gal4 kept in the 455 dark, exposed to light, exposed to light for 24 days then moved to the dark and exposed to peroxiredoxin-3 (Prdx3), thiroredoxin-1 (Trx-1), thioredoxin-2 (Trx-2), superoxide 476
dismutase-1 (SOD-1), superoxide dismutase-2 (SOD-2) and superoxide dismutase-3 (SOD-3) 477
in transgenic Aβ C. elegans in light condition compared to control dark condition. Light-478
induced Aβ aggregation showed up-regulation in expression of Cat (**p <0.01) and down-479 regulation in expression of Trx-2 (*p <0.01) and Sod-3 (***p < 0.001). 480 481 482 with 10 nematodes per repeat; ANOVA post-test p<0.05, *). 490
Movies: 491 492
Movie 1: Elav-Gal4/UAS-Aβ-CRY2-mCh embryos kept in the dark and imaged for neurons 493
in red mCherry and glial cells Repo-QF2>QUAS-GFP. Blue laser power kept low to allow 494 imaging of glial cells, but not high enough to activate aggregation. 495 496
Movie 2: Elav-Gal4/UAS-Aβ-CRY2-mCh embryos exposed to light and imaged for neurons 497 in red mCherry and glial cells Repo-QF2>QUAS-GFP. Blue laser power at higher setting to 498 allow imaging of glial cells and activate aggregation. 499 500
Movie 3: Elav-Gal4/UAS-MyrTomato embryos exposed to light and imaged for neurons in 501 red (tdTom) and glial cells Repo-QF2>QUAS-GFP. Blue laser power at higher setting to 502 allow imaging of glial cells and control for laser damage. Figure S2 . Exposure to light drives Aβ aggregation in C. elegans strains 24h post heatshock. (a) Confocal microscopy images of mutant C. elegans 24 hours post heat-shock at 20x magnification in Aβ -HS L (no heat shock, exposed to light), Aβ HS L (with heat shock, exposed to light) and Aβ HS D (with heat shock, kept in the dark) conditions. Aβ -HS L worms are used as a control for quantifying baseline Aβ expression. Distinct puncta (yellow) can be seen in animals in Aβ HS L condition. No red fluorescence was observed in control animals without the transgene (not shown). (b) Quantification of intensity of red fluorescence measured in the animals in Aβ HS L (n = 13), Aβ HS D (n = 9) and Aβ -HS L (n = 5) conditions 24 hours post heat-shock. Difference in expression between Aβ HS L conditions and Aβ -HS L is statistically significant (p = 0.034). (C) Quantification of total area of bright puncta in the animals in Aβ HS L (n = 13), and Aβ HS D (n = 9) conditions 24 hours post heat-shock. Difference in area of fluorescence between Aβ HS L conditions and Aβ HS D is statistically significant (p = 0.031).
Figure S3. Light-induced Aβ aggregation in Drosophila embryos resulted in distinct developmental defects. (a)
Still images from a 24-hours recording of Elav-Gal4/UAS-Aβ-CRY2-mCh aggregates in a Drosophila embryo without blue light illumination resulted in normal development. Time stages t=1-6 showed embryonic development stages 12-13 (~440-620 minutes after fertilization), where germ band retraction starts and ends respectively. Germ band was 5.125mm at t=1, and retracted to 2.875mm by t=6. (b) Still images from a 24-hours recording of Elav-Gal4/UAS-Aβ-CRY2-mCh aggregates in a Drosophila embryo with blue light illumination every 2.5 minutes resulted in the arrest of embryogenesis during late germ band retraction stages. Time stages t=1-6 showed embryonic development from late stage 10 to early stage 12 (~300-460 minutes after fertilization), where germ band retraction begins (stage 12). Germ band was 5.125mm at t=1, and retracted only to 4.25mm by t=6. (c) Still images from a 24-hours recording of uniform expression AD-Gal4/UAS-Aβ-CRY2-mCh aggregates in a Drosophila embryo without blue light illumination resulted in normal development. Time stages t=1-6 showed embryonic development stages 14-16 (~620-900 minutes after fertilization), where dorsal closure of midgut and epidermis and shortening of ventral nerve cord occurs. In this case, the ventral nerve cord shortening was not clearly visible. (d) Still images from a 24-hours recording of AD-Gal4/UAS-Aβ-CRY2-mCh aggregates in a Drosophila embryo with blue light illumination at every 2.5 minutes resulted in the arrest of embryogenesis at dorsal closure stages. Time stages t=1-6 corresponded to embryonic development stage 14 (approximately 620 -680 minutes after fertilization), where dorsal closure begins.
Figure S4. Thioflavin T (ThT) staining showing the Aβ aggregation transgenic
Drosophila embryos ubiquitously expressing Aβ-CRY2-mCh. Embryos expressing Aβ-CRY2-mCh ubiquitously showed significantly lesser Aβ aggregates in the (a) dark as compared to (b) embryo exposed to light. (a, b) were imaged at 20x. (c, d) were magnified images of the box in (a, b) imaged at 63x. Figure S5 . Aβ-CRY2-mCh expressing transgenic C. elegans and Drosophila reared in light showed signs of reduced fitness. (a) Exposing Aβ-CRY2-mCh C. elegans to blue light significantly reduced progeny numbers. Two-way ANOVA, p = 0.1. Data were sampled over three days (Days 6-8), n=8 light and dark worms. (b) MD-Gal4 driven Aβ-CRY2-mCh transgenic Drosophila produced significantly lower number of progeny when exposed to blue light. Two-way ANOVA ****p < 0.0001. Data were sampled on Days 5, 6, 7, 13, 14, and 20, n= 25 light and dark pairs of Drosophila. (c) Aβ-CRY2-mCh C. elegans have significantly reduced locomotive ability when reared in light. Distance travelled was reduced by about three-folds compared to the dark control and non-heat shocked control. Data were sampled on Days 9 and 10, two-way ANOVA **p < 0.01 n= 6 light, dark and non-heat shocked controls. (d) Climbing assay showed that transgenic Aβ Drosophila displayed sensorimotor impairments when exposed to light. Two-way ANOVA ****p < 0.0001. n= 18 light and dark conditions. 
